Medijane Holdings Inc (MJMD) 4.0000 $MJMD
Phoenix Life Sciences to Acquire Phoenix Bio Pharmaceuticals
ACCESSWIRE - Fri Aug 19, 10:16AM CDT
DENVER, CO / ACCESSWIRE / August 19, 2016 / Phoenix Life Sciences, Inc. ("Phoenix Life"

a private company within the healthcare and biotech industries, is pleased to announce that a Letter of Intent has been executed for the acquisition of Phoenix Bio Pharmaceuticals Corporation ("Phoenix Bio Pharmaceuticals"

. Phoenix Bio Pharmaceuticals is a privately held company with a focus on the research, development and commercialization of intellectual property assets. The current intellectual property portfolio consists of condition-specific formulations, multiple proprietary compounds, extraction technology, and delivery systems for medical cannabis products.
Letter of Intent for Merger Between MediJane and Phoenix Life Sciences
ACCESSWIRE - Tue Aug 09, 5:32PM CDT
DENVER, CO / ACCESSWIRE / August 9, 2016 / MediJane Holdings, Inc. ("MediJane"

(OTC: MJMD) a publicly-traded company, operating as a wholesaler and product distribution company within the legalized cannabis industries, is pleased to announce that a letter of intent ("LOI"

for a reorganization and merger between MJMD and Phoenix Life Sciences has been executed. Phoenix Life Sciences, Inc. ("Phoenix Life"

is a privately held company with a focus on research and development of pharmaceutical grade CBD products.
MediJane Holdings Inc Announces 2016 Strategic Plan
ACCESSWIRE - Thu Jul 30, 8:10AM CDT
LONGMONT, CO / ACCESSWIRE / July 30, 2015 / MediJane Holdings, Inc. ("MediJane"

a publicly-trade company (OTCMarkets: MJMD), operating as a wholesaler and product distribution company within the legalized cannabis industries, is pleased to announce its fiscal year 2016 strategic plan for refocusing, restructuring and recapitalization.